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Abstract. Causes of cognitive impairments development and their manifestations in patients with arterial 
hypertension. Krotova V.Yu., Khomazyuk Т.А. The article considers risk factors for the development of cognitive 
disorders, the most powerful of which is age. The role of the cardiovascular system diseases in the formation of 
cognitive impairments, in particular, the development of changes in the cognitive sphere in arterial hypertension, is 
reflected. The main causes of the appearance and clinical variants of the manifestation of cognitive impairment in 
patients with arterial hypertension are highlighted. Attention is paid to morpho-functional changes in the brain, large 
and small cerebral vessels in the increased blood pressure and their relationship to cognitive impairments. The 
indications to the study of the cognitive sphere and the variants of diagnosis of cognitive impairments in patients with 
arterial hypertension are reflected. 
 
Реферат. Причини формування  когнітивних порушень та їх прояви у хворих на артеріальну гіпертензію. 
Кротова В.Ю., Хомазюк Т.А. У статті розглянуті фактори ризику розвитку когнітивних порушень, 
найбільш сильним серед яких визнаний вік. Відображено роль захворювань серцево-судинної системи у 
формуванні когнітивних порушень, зокрема розвиток змін когнітивної сфери при артеріальній гіпертензії. 
Висвітлено основні причини появи і клінічні варіанти прояву когнітивних порушень у пацієнтів з артеріальною 
гіпертензією. Приділено увагу морфо-функціональним змінам у головному мозку, у великих і малих церебральних 
судинах при підвищенні артеріального тиску і їх взаємозв'язок з когнітивними порушеннями. Відображено 
показання до дослідження когнітивної сфери й варіанти діагностики когнітивних порушень у пацієнтів з 
артеріальною гіпертензією. 
 
Generally accepted and the most strong and in-
dependent risk factor for cognitive impairment (CI) 
is age because the brain undergoes a series of regular 
changes that make it more vulnerable to various 
pathological effects. Thus, with age, the mass of the 
brain decreases as well as, the number of synapses, 
the activity of dopaminergic, noradrenergic, acety-
lcholinergic and other neurotransmitter systems 
changes. These involutive changes ultimately reduce 
neuronal flexibility. [14, 15]. A known disorder of 
cognitive function is Alzheimer's (AD) disease, 
which is a genetically determined disease. AD 
beginning to 60 years is characterized by autosomal 
dominant type of transmission and high penetrance 
of pathological genes. [20, 37]. In addition to age 
and heredity, an important risk factor for cognitive 
impairment is cardiovascular disease, especially 
arterial hypertension (AH). In AH the risk of de-
veloping vascular dementia is higher by 62% at the 
age of 30-50 years [3, 26]. 
According to the European Congress on Hyper-
tension (ESH  ̶  Barcelona, 2018), more than 1 bil-
lion people in the world are prone to steady rise in 
blood pressure (BP), (Mancia, J Hypertens 2018). In 
Europe AH is observed in 44% of the adult 
population, in the USA and Canada ̶ 28% [24]. The 
dynamics of statistical indicators of the health of the 
population of Ukraine testifies to the unceasing 
increase in the prevalence of AH. According to the 
official data of the Center for Medical Statistics of 
the Ministry of Health in Ukraine, more than 12 
million patients with AH have been registered in 
Ukraine, accounting for about one third of the adult 
population (30% in urban areas and 36% in rural 
areas). The specific gravity of AH in the structure of 
the prevalence and morbidity of diseases of the 
circulatory system is the highest for all age groups: 
adults – 46.8% and 41.8% respectively; able-bodied 
55,2% and 46,0%. The analysis of the overall 
mortality rate in Ukraine shows that mortality from 
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cardiovascular diseases (CVD) is 61.6% among all 
causes of mortality. According to WHO data, 17.5 
million patients die from CVD, but one of the most 
common circulatory diseases is AH, in which the 
risk of cerebrovascular disease increases 3-fold [19, 
33]. The attention of the international medical com-
munity to AH as a factor in lesion of many organs 
and systems and one of the leading causes of 
mortality in the able-bodied population has been 
tracked since the beginning of the past century after 
the research conducted in Europe. Epidemiological 
studies of Systolic Hypertension in Europe trials, 
PROGRESS, LIFE, SCOPE, and MOSES have 
convincingly shown that AH is a significant risk 
factor for the development and progression of 
cognitive impairment [21, 27, 28, 32, 34, 36]. 
According to large population studies conducted 
in different regions of the world independently of 
each other, it was concluded that the presence of AH 
in the middle age is associated with an increased risk 
of developing memory impairments in the elderly 
and senile age [35, 38]. Possible mechanisms by 
which AH provokes the onset or clinical mani-
festation of AD, is currently being clarified. Most 
likely decompensation of the subclinically occurring 
degenerative process as a result of lacunar infarcts 
and/or progression of leukoareosis [18, 22, 29, 30] is 
a decisive factor. Recently, it has been proven that 
type 2 diabetes also significantly increases the risk 
of cognitive impairments. According to the LADIS 
study (European study on the relationship between 
leukoarayosis and disability study), there is a 
statistical association between diabetes mellitus and 
a characteristic marker of the neurodegenerative 
process - atrophy of the medial parts of the temporal 
parts of the brain [6, 31]. Hyperlipidemia and abdo-
minal obesity in the middle age also increase the risk 
of developing cognitive impairment as aging. 
Expected ly that the maximum risk is observed in 
the combination of AH, hyperlipidemia, abdominal 
obesity and type 2 diabetes, which is often observed 
in patients with a so-called "metabolic syndrome". 
The periventricular zone of white substance is 
considered as a zone of terminal blood supply, 
which determines its specific sensitivity to both 
elevated blood pressure levels and hypotension. 
The primary lesion of the subcortical basal 
ganglia and deep sections of the white substance of 
the cerebral hemispheres is caused by anatomical 
and physiological features of the cerebral circu-
lation. These structures are located in the so-called 
watershed area between the carotid and vertebro-
basilar basins, that is why they are the most typical 
localization of "mute" infarcts and leukoareosis as a 
result of microangiopathy of penetrating cerebral 
arteries with long-term uncontrolled AH. Damage to 
the deep sections of the white substance of the brain 
and basal ganglia involves a functional disruption of 
the prefrontal subcortical associa (separation pheno-
menon), which plays a leading role in the formation 
of the main clinical syndromes: cognitive, emotional 
and motor disorders [23].  
The proven risk factors for cognitive impairment 
in the elderly include cranio-cerebral trauma and 
episodes of history of depression, female sex, 
deficiency of B group vitamins and folic acid, low 
intellectual and physical activity in young and 
middle years of life [2, 16, 17]. There is a direct 
correlation between the level of blood pressure at the 
age of 50 years and the state of thinking at the age 
70 years: the of better the control of blood pressure, 
the better the cognitive function. Thus, AH is today 
considered as a risk factor for dementia of any 
etiology. 
Risk factors for cognitive impairments in AH: 
• uncontrolled AH, 
• hypertensive crises (violation of the blood-brain 
barrier), 
• high variability of blood pressure, 
• high nightly arterial hypertension 
("nightpeaker"), 
• excessive reduction of blood pressure at night 
time ("overdipper") and/or in the afternoon [11, 12, 
28, 35]. 
Risk factors for the development of leukoareosis 
and hypertonic angio-encephalopathy: 
1. Uncontrolled hypertension, including the so-
called "soft" AH. 
2. Hypertensive crises (breakdown of the upper 
border of autoregulation, violation of the blood-brain 
barrier). 
3. High variability of blood pressure. 
4. High night hypertension. 
5. Excessive reduction of blood pressure. 
6. High pulse pressure. 
7. Episodes of orthostatic hypotension. 
8. Age (> 60 years) [1, 9, 10]. 
Cognitive impairments are classified according 
severity. Light, moderate, and heavy CI are distin-
guished [4]. If due to CI a partial or complete depen-
dence from outside help develops, it is a case of 
severe CI (dementia). The obvious question is: when 
and who to evaluate cognitive functions? This 
should be done in middle-aged patients when there 
are complaints of memory loss or decreased con-
centration of attention; if relatives indicate to a 
cognitive decline in recent years; when there are 
problems to present anamnesis or to correctly follow 
the doctor's recommendations; in case when the 
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patient, in response to a question from the doctor, 
redirects the question to the accompanying relative.  
Patients with AH have lower results in all neu-
ropsychological tests: 
• reaction time, 
• spatial and visual memory, 
• direct and delayed playback of memorized 
words, 
• rate of the reaction of choice, 
• analysis of information, 
• solving problems, 
• revealing similarities and differences, 
• generalization, activity, motivation, program-
ming action, 
• state arbitrary attention [28]. 
For diagnostics of CI in clinical trials, in clinical 
practice and scientific research, neuropsychological 
research methods are most often used. The most 
popular and easy-to-interpret techniques are the 
Mini-Mental State Examination (MMSE) [25], Fron-
tal Assessment Battery (FAB) [8], the clock drawing 
test, and the Global Deterioration Scale Rating [5]. 
The implementation of complex neuropsycho-
logical tests depends on dynamic factors such as 
concentration of attention, the mood of the patient, 
his motivation to achieve maximum results. Of great 
importance are the level of education and premorbid 
mnestic-intellectual abilities [15]. 
For practical purposes, timely diagnosis of CI is 
important, since it is precisely in the early stages of 
brain damage that one can expect the greatest suc-
cess of therapeutic measures. Clinical manifestations 
of light and moderate CI depend on the cause of the 
violations. In the early stages of Alzheimer's disease, 
in the clinical picture memory impairments domi-
nate. The most specific symptoms are the inability to 
remember the names of recent acquaintances or to 
retell the newly read, difficulty in selecting the right 
word in the conversation. In light CI associated with 
the predominant lesion to subcortical basal ganglia 
and the most frequent variants of vascular cerebral 
insufficiency, the "clinical subcortical-frontal" CI 
appears in the foreground of the plan view as a 
violation of the planning and switching activity, re-
ducing the reaction rate and mental performance, 
impulsive behavior. Such disorders are usually ac-
companied by symptoms of depression and neuro-
logical disorders [7]. 
It is not clear finally by how much is the effect of 
AH on CF in younger patients is expressed. Howe-
ver, there is evidence that even in adolescence, a 
higher level of AS is associated with the decrease in 
mathematical and creative abilities. At present, AH 
is considered as a factor accelerating the realisation 
of the genetic predisposition to the degenerative 
process in the brain (Lande M., et al., 2013).  
Thus, it should be emphasized that to detect 
cognitive impairment in patients with cardiovascular 
diseases including those with arterial hypertension, 
especially at early, pre-dimential stages, identifying 
the cause of their development is important for 
primary care physicians, since this impact the 
effectiveness of treatment, duration and quality of 
their life. 
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Реферат. Изменения параметров функции внешнего дыхания у больных с терминальной стадией 
хронической болезни почек, которые находятся на заместительной терапии. Курята A.В., Штепа О.A., 
Галущак О.В. Целью нашей работы было проанализировать изменения показателей функции внешнего 
дыхания (ФВД) у больных с терминальной стадией болезни почек в условиях проведения заместительной 
терапии и сравнить с результатами у больных после трансплантации почек. В первую группу вошли 40 
больных с терминальной стадией хронической болезни почек, которые находятся на гемодиализе. Во вторую 
группу – 19 больных после трансплантации почки. Была определена достоверная разница (р˂ 0,05) у больных 
первой и второй групп между показателями ФЖЕЛ (90 [75-110]% и 98 [91-108]%), ОФВ1 (79 [71-93]% и 96 
[84-104]%), ПОС (61 [40-87]% и 82 [64-94]%), СОС25-75 (52,5 [39-71]% и 80 [66-112]%). Показатели обеих 
групп достоверно отличались относительно показателей ФВД группы сравнения: ФЖЕЛ (107,5 [105,5-124]%), 
ОФВ1 (100,5 [96-105,5]%), ПОС (99,5 [95-102,5]%), СОС25-75 (98,5 [97,5-101,5]%). У больных первой группы 
